In a meta‐analysis, estimated HER2 overexpression and ERBB2 gene amplification rates were higher in extrahepatic biliary tract carcinomas than in intrahepatic cholangiocarcinoma (19.9% vs. 4.8%).20 Here, ERBB2 is linked to cholangiocarcinoma.